Age-stratified risk factors of re-intervention for uterine fibroids treated with high-intensity focused ultrasound

Int J Gynaecol Obstet. 2024 Mar;164(3):1212-1219. doi: 10.1002/ijgo.15217. Epub 2023 Nov 12.

Abstract

Objective: To estimate the rate and risk factors of re-intervention for patients with uterine fibroids (UFs) undergoing high-intensity focused ultrasound (HIFU) at different age distributions.

Method: A retrospective cohort study was conducted in Nanchong Central Hospital, recruiting a total of 672 patients with UFs undergoing HIFU from June 2017 to December 2019. Using univariate and multivariate logistic regression, risk factors for re-intervention were assessed.

Results: Among 401 patients with UFs who completed the follow-up visits (median 47 months, range 34-61), 50 (12.46%) patients underwent re-intervention (such as high-intensity focused ultrasound, uterine artery embolization, myomectomy and hysterectomy). In the different age distributions, the re-intervention rate was 17.5% (34/194) in patients aged <45 years and 7.7% (16/207) in those aged ≥45 years. Regarding the younger patient group (aged <45 years), hypo- or iso-intensive fibroids in T2-weighted magnetic resonance imaging (T2WI) intensity may elevate the risk of re-intervention for UFs (odds ratio [OR] 2.96, 95% confidence interval [CI] 1.37-6.62; P = 0.007). Among the older patient group (aged ≥45 years), preoperative anemic patients had an increased risk of re-intervention compared with those without anemia (OR 3.30, 95% CI 1.01-10.37; P = 0.041).

Conclusion: The re-intervention rate of HIFU decreased with increasing age. Among those aged <45 years, T2WI intensity was the independent risk factor for re-intervention, and among those aged ≥45 years, preoperative anemic status may be related to re-intervention outcome.

Keywords: age; high-intensity focused ultrasound; re-intervention; risk factor; uterine fibroids.

MeSH terms

  • Female
  • High-Intensity Focused Ultrasound Ablation* / methods
  • Humans
  • Leiomyoma* / surgery
  • Magnetic Resonance Imaging / methods
  • Retrospective Studies
  • Treatment Outcome
  • Uterine Myomectomy* / adverse effects
  • Uterine Neoplasms* / surgery